Kiromic BioPharma OverviewKiromic BioPharma EBIT
EBIT (Earnings Before Interest and Taxes) analysis for KRBP.
Quarterly EBIT
-$5.73M
↓ 41.07% YoY
As of Dec 31, 2024
Annual EBIT (TTM)
-$24.35M
↓ 41.13% YoY
Trailing 12 months ending Dec 31, 2024
Kiromic BioPharma OverviewEBIT (Earnings Before Interest and Taxes) analysis for KRBP.
As of Dec 31, 2024
Trailing 12 months ending Dec 31, 2024